As discussed above, our data [19] (and that reported here) imply that MYB is required in ER positive mammary carcinoma cells for three key 'hallmarks of cancer' [58] - continued proliferation, suppression of differentiation, and resistance to apoptosis. This evidence concerns the gene MYB and cancer.